Abstract submission is now open.

SUBMISISON DEADLINE: Monday, January 2, 2023

NOTIFICATION DATE: January 9, 2023

Encore posters are welcome!

We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:

• Future of Medical Dermatology
  • Atopic Dermatitis
  • Hyperhidrosis
  • Acne
  • Vitiligo
  • Psoriasis
  • Scar & Keloids
  • Hidradenitis Suppurativas
  • Photoprotection
• Clinical Updates in Pediatric Dermatology
  • Birthmarks
  • Acne
  • Pediatric Atopic Dermatitis
  • Eczema and Other Inflammatory Diseases
  • Urticarial Lesions
  • Scar Wars
• Aesthetics & Procedural Dermatology
  • Toxins and Fillers
  • Cosmeceuticals
  • Energy-Based Devices
  • Skin Tightening
  • Microneedling
  • Body Contouring
  • Cellulite
• Melanoma & Cutaneous Oncology
  • Merkel Cell Carcinoma
  • CTCL
  • Imaging & Blood Work for Melanoma Patients
  • MOHS – What Dermatologists Need to Know
  • Teledermatology

At least one (1) author must be registered for the in-person meeting to have their abstracts considered for oral presentation and/or poster display. All submissions accepted for oral presentation must also create a poster for display.

All accepted abstracts will be displayed at the 45th Annual Hawaii Dermatology Seminar, February 19th – 24th, to be held at the Waikiki Beach Marriott, Waikiki, Hawaii.

All accepted abstracts will be included as an Abstract Compendium supplement to be distributed with the print version of Cutis, a peer reviewed and INDEXED in Medicus/MEDLINE journal.

In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.

Download the App:

​

If you are returning to complete or check the status of your submission, please sign-in (link sign-in to the main sign-in page of the abstract page and then delete this parentheses) using your email address and password.

Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts.

A portion of the proceeds from the registration and abstract fees will be donated to a charity.

Abstract Formatting and Content Guidelines
You must be registered for the meeting to have your abstract considered for a presentation.

• Language: English 
• Authors: full last name, first name, affiliations, degrees and contact information
• Font: Arial
• Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
• Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg 
• References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)
• Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email) 
• Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions 
• Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.

If you have any questions, please contact Tristan Nelsen at tnelsen@medscapelive.com.